These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9706048)
21. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease. Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491 [TBL] [Abstract][Full Text] [Related]
22. Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications. Alexander A; Ajazuddin ; Khan J; Saraf S; Saraf S Eur J Pharm Biopharm; 2014 Nov; 88(3):575-85. PubMed ID: 25092423 [TBL] [Abstract][Full Text] [Related]
23. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Zaki NM; Awad GA; Mortada ND; Abd Elhady SS Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822 [TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel. Kesarla R; Tank T; Vora PA; Shah T; Parmar S; Omri A Drug Deliv; 2016 Sep; 23(7):2363-2370. PubMed ID: 25579467 [TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease. Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639 [TBL] [Abstract][Full Text] [Related]
26. Development of Intra-knee Joint Sustained-Release Gel Formulation and Evaluation of Its Pharmacological Efficiency in Rats. Noda T; Okuda T; Ban K; Mizuno R; Tagami T; Ozeki T; Okamoto H Biol Pharm Bull; 2017 Jun; 40(6):830-836. PubMed ID: 28100866 [TBL] [Abstract][Full Text] [Related]
27. Novel self-assembled tacrolimus nanoparticles cross-linking thermosensitive hydrogels for local rheumatoid arthritis therapy. Wu H; Wang K; Wang H; Chen F; Huang W; Chen Y; Chen J; Tao J; Wen X; Xiong S Colloids Surf B Biointerfaces; 2017 Jan; 149():97-104. PubMed ID: 27736727 [TBL] [Abstract][Full Text] [Related]
28. Reverse thermal gelation of aliphatically modified biodegradable triblock copolymers. Jo S; Kim J; Kim SW Macromol Biosci; 2006 Nov; 6(11):923-8. PubMed ID: 17099865 [TBL] [Abstract][Full Text] [Related]
29. In Situ Forming Depot as Sustained-Release Drug Delivery Systems. Kanwar N; Sinha VR Crit Rev Ther Drug Carrier Syst; 2019; 36(2):93-136. PubMed ID: 30806210 [TBL] [Abstract][Full Text] [Related]
30. Thermogelling chitosan-g-(PAF-PEG) aqueous solution as an injectable scaffold. Kang EY; Moon HJ; Joo MK; Jeong B Biomacromolecules; 2012 Jun; 13(6):1750-7. PubMed ID: 22607186 [TBL] [Abstract][Full Text] [Related]
31. Control of rhGH Release Profile from PEG-PAF Thermogel. Shinde UP; Moon HJ; Ko du Y; Jung BK; Jeong B Biomacromolecules; 2015 May; 16(5):1461-9. PubMed ID: 25849077 [TBL] [Abstract][Full Text] [Related]
32. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel: part 1--Synthesis, characterization, and acute toxicity evaluation. Gong CY; Shi S; Dong PW; Yang B; Qi XR; Guo G; Gu YC; Zhao X; Wei YQ; Qian ZY J Pharm Sci; 2009 Dec; 98(12):4684-94. PubMed ID: 19367619 [TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel. Yu L; Li K; Liu X; Chen C; Bao Y; Ci T; Chen Q; Ding J J Pharm Sci; 2013 Nov; 102(11):4140-9. PubMed ID: 24114868 [TBL] [Abstract][Full Text] [Related]
34. Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study. Gong CY; Dong PW; Shi S; Fu SZ; Yang JL; Guo G; Zhao X; Wei YQ; Qian ZY J Pharm Sci; 2009 Oct; 98(10):3707-17. PubMed ID: 19189419 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Gong C; Shi S; Dong P; Kan B; Gou M; Wang X; Li X; Luo F; Zhao X; Wei Y; Qian Z Int J Pharm; 2009 Jan; 365(1-2):89-99. PubMed ID: 18793709 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice. Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009 [TBL] [Abstract][Full Text] [Related]
37. Site-specific delivery of oligonucleotides to hepatocytes after systemic administration. Zhu L; Ye Z; Cheng K; Miller DD; Mahato RI Bioconjug Chem; 2008 Jan; 19(1):290-8. PubMed ID: 17850109 [TBL] [Abstract][Full Text] [Related]
38. In situ gel systems as 'smart' carriers for sustained ocular drug delivery. Agrawal AK; Das M; Jain S Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, biodegradability and biocompatibility of a temperature-sensitive PBLA-PEG-PBLA hydrogel as protein delivery system with low critical gelation concentration. Xu Y; Shen Y; Xiong Y; Li C; Sun C; Ouahab A; Tu J Drug Dev Ind Pharm; 2014 Sep; 40(9):1264-75. PubMed ID: 23855735 [TBL] [Abstract][Full Text] [Related]
40. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer. Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]